SUN.KING TECH (00580) plans to establish a joint venture company to invest in high-performance TPU AI chip-related business.
SAIC Crystal Technology (00580) announced that on September 9, 2026, Jiaxing SAIC, SAIC Semiconductor, Wuhan Langde, and other joint venture partners signed an investment cooperation agreement. According to this agreement, the joint venture partners will establish a joint venture company with a registered capital of RMB 20 million, in which Jiaxing SAIC, SAIC Semiconductor, and Wuhan Langde (all subsidiaries of the company) will jointly contribute a total of RMB 5 million (accounting for 25% of the joint venture company's equity) in accordance with their respective equity ratios in the joint venture.
SUN.KING TECH (00580) announced that on September 9, 2026, Jiaxin Saijing, Saijing Semiconductor, Wuhan Langde, and other joint venture partners signed an investment cooperation agreement, according to which the joint venture partners will establish a joint venture company with a registered capital of RMB 20 million. Among them, Jiaxin Saijing, Saijing Semiconductor, and Wuhan Langde (all of which are subsidiaries of the company) will contribute a total of RMB 5 million (representing 25% of the joint venture company's equity) according to their respective equity ratios in the joint venture.
The joint venture company will primarily engage in the research and development, production, and sales of high-performance TPU AI chips and industry inference products (including customized AI acceleration cards, edge inference industrial computers, high-performance AI workstations, and industry large model integrated machines).
By establishing the joint venture company to jointly invest in high-performance TPU AI chip-related business, the partners can achieve complementary advantages in management experience and expertise in the chip business; on the other hand, it can assist the group in upgrading its business expansion in the AI field, expanding the groups industrial layout, and strengthening the group's competitiveness.
Related Articles

PW MEDTECH (01358) spent HKD 390,300 on September 9 to buy back 402,000 shares.

BOAN BIOTECH (06955) spent HKD 2.922 million on September 9 to repurchase 1 million shares.

DINGDANG HEALTH (09886) invested HK$336,300 to repurchase 420,000 shares on September 9.
PW MEDTECH (01358) spent HKD 390,300 on September 9 to buy back 402,000 shares.

BOAN BIOTECH (06955) spent HKD 2.922 million on September 9 to repurchase 1 million shares.

DINGDANG HEALTH (09886) invested HK$336,300 to repurchase 420,000 shares on September 9.

RECOMMEND





